bearish
Celltrion Healthcare IPO Part 5 - Regulatory Concerns & Possible M&A Options
193 Views17 Jul 2017 13:39
Korea's Anti-Trust Law now says that any business group (those so-called chaebols or large conglomerates) with combined assets of ₩10tril are...
SUMMARY
(Sign Up to Access)Begin exploring Smartkarma's AI-augmented investing intelligence platform with a complimentary Preview Pass to:
- Unlock research summaries
- Follow top, independent analysts
- Receive personalised alerts
- Access Analytics, Events and more
Join 55,000+ investors, including top global asset managers overseeing $13+ trillion.
Upgrade later to our paid plans for full-access.
or
Already have an account? Sign In Now
Full Insight
(Paid Plans Only, 4-minute read)
Discussions
(Paid Plans Only)
Price Chart(Sign Up to Access)
- Biogen Likes Biosimilars25 Jul 2017
- JNJ's REMICADE Holds: PFE's Results To Confirm19 Jul 2017
- Celltrion Healthcare IPO Part 6 - IPO Bookbuilding Results17 Jul 2017
- Celltrion Healthcare IPO Part 4 - Valuation & Pricing Debate12 Jul 2017
- Celltrion Healthcare IPO Part 3 - What Local Institutions Seem to Have in Mind03 Jul 2017
x